Program Role: Dr. Julia Schaletzky is an interdisciplinary biomedical scientist and entrepreneur active both in the private sector and in academia. She is a Drug Discovery and Biotechnology expert and the Executive Director of the Center for Emerging and Neglected Diseases at the University of California, Berkeley, as well as of the Drug Discovery Center and Immunotherapy and Vaccine Research Initiative. A lecturer at the Haas School of Business, she leads the freshman Intro to Biotech course, lectures in the senior capstone class, and serves as an LSBE curriculum consultant and biotechnology expert.
Research: After studying biochemistry in her native Germany, she moved to Harvard Medical School for graduate school. Interested in applied science, Dr. Schaletzky joined a biotechnology company, Cytokinetics, to develop new therapies for heart disease and neurodegenerative disorders, with several molecules in late-stage clinical trials. In her role at UC Berkeley, she focuses on interdisciplinary approaches and public/private partnership for the discovery and development of new therapies and tools, particularly for unmet medical needs. A lecturer at the Haas School of Business, she teaches Bioentrepreneurship, Access to Medicines and Drug Development for Neglected Diseases. She has received NIH-funded grants to support underrepresented minorities and women in STEM in the U.S., and runs a program in Uganda to build local research capacity. Dr. Schaletzky is broadly interested in bioentrepreneurship, global public health, health equity, and the governance of processes that end up influencing who gets care and who does not.